These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7668092)

  • 1. Residual inhibition in density of [3H]isradipine binding sites in rat brain membrane pretreated with amlodipine.
    Qu YL; Takamizawa C; Sugiyama K; Maruyama K; Hattori K; Watanabe K; Nagatomo T
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):289-93. PubMed ID: 7668092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blocking properties of SM-6586 in rat heart and brain as assessed by radioligand binding assay.
    Qu YL; Sugiyama K; Nagatomo T; Maniwa T; Miyagishi A
    Jpn J Pharmacol; 1993 Oct; 63(2):165-9. PubMed ID: 8283826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow dissociation of long-acting Ca2+ antagonist amlodipine from 3H-PN200-110 binding sites in membranes of rat hearts and brains.
    Sugiyama K; Qu YL; Maruyama K; Hattori K; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Feb; 19(2):195-8. PubMed ID: 8850304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of binding affinities of omega-conotoxin and amlodipine to N-type Ca2+ channels in rat brain.
    Qu YL; Sugiyama K; Ohnuki T; Hattori K; Watanabe K; Nagatomo T
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):97-100. PubMed ID: 10374627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
    Nakajima M; Adachi I; Ueda M
    Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique binding properties of amlodipine: a long-acting calcium antagonist.
    Nayler WG; Gu XH
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.
    Yamada S; Uchida S; Ohkura T; Kimura R; Yamaguchi M; Suzuki M; Yamamoto M
    J Pharmacol Exp Ther; 1996 May; 277(2):721-7. PubMed ID: 8627551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.
    Yamada S; Matsuoka Y; Kato Y; Kimura R; Inagaki O
    J Pharmacol Exp Ther; 1992 Aug; 262(2):589-94. PubMed ID: 1323654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
    Matthes J; Huber I; Haaf O; Antepohl W; Striessnig J; Herzig S
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):578-83. PubMed ID: 10882031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation.
    Ebersole BJ; Molinoff PB
    J Pharmacol Exp Ther; 1991 Oct; 259(1):337-44. PubMed ID: 1833526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery.
    Matlib MA
    Am J Cardiol; 1989 Nov; 64(17):51I-57I. PubMed ID: 2530885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
    Melena J; Osborne NN
    Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.